We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
Cap. Flow
+$418M
Cap. Flow %
0.12%
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 32.82%
2 Financials 13.01%
3 Consumer Discretionary 11.23%
4 Communication Services 9.04%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCO icon
2976
Clear Channel Outdoor Holdings
CCO
$1.23B
$334K ﹤0.01%
285,340
-1,166,831
-80% -$1.26M
CVAC
2977
DELISTED
CureVac
CVAC
$332K ﹤0.01%
61,831
-21,388
-26% -$84.8K
HSHP
2978
Himalaya Shipping
HSHP
$760M
$331K ﹤0.01%
57,398
-14,156
-20% -$78.9K
IHRT icon
2979
iHeartMedia
IHRT
$535M
$331K ﹤0.01%
188,137
ESSA
2980
DELISTED
ESSA Bancorp
ESSA
$331K ﹤0.01%
17,044
+4,372
+35% +$80.8K
ALTG icon
2981
Alta Equipment Group
ALTG
$210M
$328K ﹤0.01%
51,838
-8,812
-15% -$44.6K
USCB icon
2982
USCB Financial Holdings
USCB
$396M
$327K ﹤0.01%
19,796
+4,232
+27% +$71.1K
DRUG
2983
Bright Minds Biosciences
DRUG
$700M
$326K ﹤0.01%
+12,487
New +$374K
SMC
2984
Summit Midstream
SMC
$421M
$325K ﹤0.01%
+13,253
New +$364K
KWY
2985
Kingsway Corp
KWY
$249M
$324K ﹤0.01%
23,957
+6,402
+36% +$68K
UTMD icon
2986
Utah Medical Products
UTMD
$214M
$323K ﹤0.01%
5,669
-2,349
-29% -$128K
ABEO icon
2987
Abeona Therapeutics
ABEO
$345M
$322K ﹤0.01%
+56,719
New +$323K
TRAK icon
2988
ReposiTrak
TRAK
$148M
$322K ﹤0.01%
16,364
-5,466
-25% -$115K
ANIK icon
2989
Anika Therapeutics
ANIK
$199M
$321K ﹤0.01%
30,372
-10,943
-26% -$138K
DCGO icon
2990
DocGo
DCGO
$58.9M
$321K ﹤0.01%
204,561
-41,284
-17% -$76.9K
XOMA
2991
DELISTED
Xoma
XOMA
$320K ﹤0.01%
12,706
-1,657
-12% -$39.7K
BRCC icon
2992
BRC Inc
BRCC
$126M
$319K ﹤0.01%
243,763
+120,748
+98% +$223K
ADCT icon
2993
ADC Therapeutics
ADCT
$146M
$319K ﹤0.01%
118,915
-33,132
-22% -$69.7K
BARK icon
2994
BARK
BARK
$74.8M
$318K ﹤0.01%
18,082
-3,123
-15% -$71.7K
ADV icon
2995
Advantage Solutions
ADV
$484M
$317K ﹤0.01%
9,603
-6,127
-39% -$202K
CTRN icon
2996
Citi Trends
CTRN
$524M
$317K ﹤0.01%
9,485
-5,500,527
-100% -$140M
REFI
2997
Chicago Atlantic Real Estate Finance
REFI
$258M
$317K ﹤0.01%
22,675
-13,424
-37% -$193K
EGAN icon
2998
eGain
EGAN
$176M
$314K ﹤0.01%
50,250
-10,699
-18% -$57.2K
RCEL icon
2999
Avita Medical
RCEL
$142M
$314K ﹤0.01%
59,316
-12,422
-17% -$90.4K
KGEI
3000
Kolibri Global Energy
KGEI
$189M
$313K ﹤0.01%
+45,762
New +$315K

Similar funds

Nuveen's Q2 2025 Portfolio in Review

As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
  • Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
  • Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
  • Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
  • Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
  • Nuveen opened 192 new positions and closed 199 in Q2 2025.
  • Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.